News Headlines Article

FDA approves new cholesterol drug – at $14,600 a year
USA Today

Up to 10 million Americans will soon have a new option for lowering their cholesterol – at a price of $14,600 a year.

The Food and Drug Administration surprised much of the medical community Friday by broadly approving a new cholesterol drug for a vast potential patient population. The agency approved Praluent for people with an inherited condition that causes very high levels of LDL, or bad cholesterol, as well as for the millions of Americans who have had heart attacks, strokes or other types of heart disease and whose LDL is higher than it should be.

Commands